ROBERT MURRAY: Open Payments
NPI 1346359353 · WOLFEBORO, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$361 in 17 payments from 10 companies in 2025. Trend: 2023 $560 · 2024 $592 · 2025 $361
Food & beverage: $361
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $86 |
| ABBVIE INC. | 3 | $54 |
| Alkermes, Inc. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 1 | $37 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $14 |
Products named: COBENFY, VRAYLAR, ARISTADA, REXULTI, INGREZZA, Auvelity, INVEGA SUSTENNA, CAPLYTA.
Industry payments across NH — which companies pay providers there.
